ID WSU-ALCL AC CVCL_A036 DR BioSample; SAMN03151623 DR cancercelllines; CVCL_A036 DR Cosmic; 1086369 DR Wikidata; Q54994463 RX CelloPub=CLPUB00128; RX PubMed=8558920; RX PubMed=12592342; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a malignant pleural effusion of a 18 year old patient with primary refractory anaplastic large cell lymphoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00284. CC Population: Caucasian. CC Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: T-cell; CL=CL_0000084. DI NCIt; C7953; Childhood T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0207 ! CCRF-CEM SX Female AG 3Y11M CA Cancer cell line DT Created: 06-06-12; Last updated: 10-04-25; Version: 29 // RX PubMed=12592342; DOI=10.1038/sj.leu.2402799; RA Drexler, Hans Gunther RA Dirks, Wilhelm Gerhard RA Matsuo, Yoshinobu RA MacLeod, Roderick A.F. RT "False leukemia-lymphoma cell lines: an update on over 500 cell RT lines."; RL Leukemia 17:416-426(2003). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=8558920; RA Dirks, Wilhelm Gerhard RA Zaborski, Margarete RA Jager, Kathrin RA Challier, Cecile RA Shiota, Mami RA Quentmeier, Hilmar RA Drexler, Hans Gunther RT "The (2;5)(p23;q35) translocation in cell lines derived from malignant RT lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines."; RL Leukemia 10:142-149(1996). // RX CelloPub=CLPUB00128; RA Al-Katib, Ayad M. RA Abubakr, Yousif A. RA Mohamed, Anwar N. RA Maki, Auday RA Djuric, Zora RA Mohammad, Ramzi M. RT "Multiple mechanisms of drug resistance in anaplastic large cell RT lymphoma."; RL Blood 84 Suppl. 1:638a.2537-638a.2537(1994). //